Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Kates

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Clinical Genitourinary Cancer|June 19, 2023
Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the BladderPranjal Agrawal, Mary Rostom, Ridwan Alam, et al.
The Prostate|January 3, 2025
Nectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical StudyEzra G Baraban, Evangelia Vlachou, Sunil Patel, et al.
World Journal of Urology|December 11, 2012
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysisChe-kai Tsao, Alexander C Small, Max Kates, et al.
Cancer Immunology Research|June 8, 2017
Intravesical BCG Induces CD4<sup>+</sup> T-Cell Expansion in an Immune Competent Model of Bladder CancerMax Kates, Thomas Nirschl, Nikolai A Sopko, et al.
Journal of Extracellular Vesicles|January 31, 2024
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancerLiang Dong, Mingxiao Feng, Morgan D Kuczler, et al.
European Urology Open Science|June 22, 2026
Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder CancerJennifer Linehan, Piyush K Agarwal, Xianne Penny, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder CancerMax Kates, Meera R Chappidi, Aaron Brant, et al.
Urologic Oncology|March 28, 2015
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomesNilay M Gandhi, Alexander Baras, Enrico Munari, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonistPeter K Um, Monali Praharaj, Kara A Lombardo, et al.
European Urology|December 6, 2025
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEvangelia Vlachou, Burles Avner Johnson, Max Kates, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Clinical Genitourinary Cancer|June 19, 2023
Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the BladderPranjal Agrawal, Mary Rostom, Ridwan Alam, et al.
The Prostate|January 3, 2025
Nectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical StudyEzra G Baraban, Evangelia Vlachou, Sunil Patel, et al.
World Journal of Urology|December 11, 2012
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysisChe-kai Tsao, Alexander C Small, Max Kates, et al.
Cancer Immunology Research|June 8, 2017
Intravesical BCG Induces CD4<sup>+</sup> T-Cell Expansion in an Immune Competent Model of Bladder CancerMax Kates, Thomas Nirschl, Nikolai A Sopko, et al.
Journal of Extracellular Vesicles|January 31, 2024
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancerLiang Dong, Mingxiao Feng, Morgan D Kuczler, et al.
European Urology Open Science|June 22, 2026
Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder CancerJennifer Linehan, Piyush K Agarwal, Xianne Penny, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder CancerMax Kates, Meera R Chappidi, Aaron Brant, et al.
Urologic Oncology|March 28, 2015
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomesNilay M Gandhi, Alexander Baras, Enrico Munari, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonistPeter K Um, Monali Praharaj, Kara A Lombardo, et al.
European Urology|December 6, 2025
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEvangelia Vlachou, Burles Avner Johnson, Max Kates, et al.
Pageof 16